Ionis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IONS and other ETFs, options, and stocks.About IONS
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T.
IONS Key Statistics
IONS News
AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock...
RBC Capital raised the firm’s price target on Ionis Pharmaceuticals (IONS) to $80 from $70 and keeps an Outperform rating on the shares. The firm’s discussion w...
Ionis Pharmaceuticals recently announced positive topline results from its Phase 3 CORE and CORE2 studies, where olezarsen achieved statistically significant re...
Analyst ratings
76%
of 29 ratingsMore IONS News
Ionis Pharmaceuticals, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Kostas Biliouris from BMO Capital maintained a H...
Despite an already strong run, Ionis Pharmaceuticals, Inc. ( ) shares have been powering on, with a gain of 34% in the last thirty days. Taking a wider view, al...
Ionis Pharmaceuticals, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Kostas Biliouris from BMO Capital upgraded the ratin...
Bank of America Securities analyst Jason Gerberry reiterated a Buy rating on Ionis Pharmaceuticals yesterday and set a price target of $69.00. Elevate Your Inve...
Shares of Ionis Pharmaceuticals (IONS) surged to a four-year high after the company’s lipid-lowering drug, Tryngolza, successfully met the primary goal in late-...
Analyst Michael Ulz from Morgan Stanley reiterated a Buy rating on Ionis Pharmaceuticals and increased the price target to $71.00 from $62.00. Elevate Your Inve...
U.S. stocks were lower, with the Dow Jones index falling over 250 points on Tuesday. Shares of Air Lease Corporation AL rose sharply during Tuesday's session a...
